IlluminOss Medical registers three new patents

EAST PROVDIENCE – IlluminOss Medical, a medical device company pioneering the development of minimally invasive fracture-fixation technologies, announced last week that it has registered three new patents for instruments used in the company’s proprietary Photodynamic Bone Stabilization System.
The patents issued were “Apparatus and Methods for Repairing Craniomaxillofacial Bones,” “Apparatus for Delivery of Reinforcing Materials to Bone,” and “Photodynamic Bone Stabilization and Drug Delivery Systems.” IlluminOss now holds 32 U.S. and international patents.
“This strong and growing IP portfolio demonstrates that we are continuing to advance our innovative fracture-fixation technologies as we expand our commercial efforts in Europe and work towards gaining regulatory approval in the United States,” said Robert Rabiner, founder and chief technology officer of IlluminOss. “With the addition of these three new patents, we can confidently say that our IP portfolio covers the whole body.”
The Photodynamic Bone Stabilization System stabilizes bone fractures or prevents impending fractures through a percutaneous, patient-customized fracture-fixation system. Using the system, clinicians insert an angioplasty-like balloon across the fracture site, which is then filled with a liquid monomer, a type of chemical binder.
Once the positioning of the implant is verified using fluoroscopy, light delivered to the site through a fiber cures the monomer for rapid stabilization of the bone.
“In addition to the robustness of our patent estate, IlluminOss is gathering compelling clinical evidence that shows how our patient-customized approach to fracture repair has the potential to improve clinical outcomes,” said Dirk Kuyper, president and CEO of IlluminOss.

No posts to display